
"After the reform of the health stock, plans listing in Hong Kong, becoming the second country Sinopharm internal control." November 2, Sinopharm insider told reporters, China National Biotec Corporation (referred to as "Group Health ") changed its name to the raw conversion shares, will become bigger and stronger biological Sinopharm Group ...Students will be listed in Hong Kong in the Temple of Heaven, or fall into the expected biological assets
No comments:
Post a Comment